Active ingredients: irinotecan
What it is used for
IRINOTECAN ALPHAPHARM is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. IRINOTECAN ALPHAPHARM is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.
How to take it
The way to take this medicine is: Intravenous Infusion.
- Store below 25 degrees Celsius
- Do not Freeze
- Protect from Light
- Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient irinotecan
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems